Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Brii Biosciences Provides Corporate Update and Reports Full-Year 2023 Financial Results 2024-03-22 19:00
The Results of Phase II Clinical Study of KN046 Plus Chemotherapy as First-line Treatment for Metastatic NSCLC were Published in Cell Reports Medicine 2024-03-22 18:42
Antengene Announces Full Year 2023 Financial Results, Highlights Clinical Progress Across First-in-Class, Best-in-Class Pipeline 2024-03-22 18:00
NeuExcell Therapeutics Announces Successful Dosing of First Patient by NeuroD1 Gene Therapy 2024-03-22 08:00
100% CBR! FDA Granted ODD to Biostar Pharma's Utidelone Capsule (UTD2) for the Treatment of Gastric Cancer 2024-03-21 20:30
FDA Grants Orphan Drug Designation to Cevidoplenib for ITP 2024-03-21 20:00
Henlius 2023 Annual Results: Revenue surpassed RMB5.39 billion with a net profit RMB546 million, first full-year profitability achieved 2024-03-21 19:47
HanAll Biopharma Reports Full-Year 2023 Financial Results and Provides Business Update 2024-03-21 19:00
Biosion to Present Three Posters at the 2024 AACR Meeting 2024-03-21 19:00
Mabwell Presented IDDC™ Platform Technology and ADC Drug Development Achievements at the 14th World ADC London 2024-03-21 14:11
SK bioscience Exports Influenza Vaccine to Thailand, Entering Southern Hemisphere Market 2024-03-21 13:24
TreeFrog's Chief Scientific Officer & Co-founder, Maxime Feyeux, to present at The 23rd Congress of the Japanese Society for Regenerative Medicine (JSRM) 2024-03-21 07:30
Jiangsu Recbio Technology Co., Ltd. announced 2023 annual results report and latest progress 2024-03-21 00:22
Antengene Initiates Phase II Dose Expansion Study of Claudin 18.2 ADC ATG-022 in China and Australia 2024-03-20 20:30
Antennova Completes First Dosing Cohort for Anti-CD24 mAb, ATN-031, in the Phase I PERFORM Study 2024-03-20 20:30
Origin Agritech Announces Breakthrough in High-Yield Corn Production Through Gene Editing 2024-03-20 20:00
Innovent Announces 2023 Annual Results and Business Updates 2024-03-20 19:44
Engrail Therapeutics Closes Oversubscribed $157M Series B Financing Round to Advance the Development of Transformational Therapies 2024-03-20 11:00
Antengene Publishes Preclinical Paper on PD-L1/4-1BB Bispecific Antibody ATG-101 in Renowned Oncology Journal Cancer Research 2024-03-20 08:30
SGO 2024 | The First Published Clinical Data of Nectin-4-Targeting ADC Developed by Mabwell in Cervical Cancer Demonstrates Its Outstanding Therapeutic Potential 2024-03-19 22:00
1 6.5 7.5 8.5 9.5 10.5 412